Most Recent Articles about NVS
Adverum Reports Data From Phase I Wet AMD Study, Stock Down http://www.zacks.com/stock/news/516878/adverum-reports-data-from-phase-i-wet-amd-study-stock-down?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-516878 Sep 13, 2019 - Adverum Biotechnologies (ADVM) announces data from one cohort of an early-stage study, evaluating its gene therapy candidate, ADVM-022, in patients with wet AMD.
Puma Biotech's sNDA for Nerlynx Combo Gets FDA Acceptance http://www.zacks.com/stock/news/515058/puma-biotechs-snda-for-nerlynx-combo-gets-fda-acceptance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-515058 Sep 12, 2019 - The FDA accepts for review Puma Biotech's (PBYI) sNDA that seeks an approval for Nerlynx in combination with Roche's Xeloda for treating third-line breast cancer.
Has Novartis (NVS) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/514961/has-novartis-nvs-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-514961 Sep 12, 2019 - Is (NVS) Outperforming Other Medical Stocks This Year?

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals